Paul Peloso - Aug 16, 2023 Form 4 Insider Report for ACELYRIN, Inc. (SLRN)

Role
Chief Medical Officer
Signature
/s/ Mina Kim, Attorney-in-fact
Stock symbol
SLRN
Transactions as of
Aug 16, 2023
Transactions value $
$0
Form type
4
Date filed
8/18/2023, 06:54 PM
Previous filing
May 11, 2023
Next filing
Oct 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRN Common Stock Award $0 +116K +1925.18% $0.00 122K Aug 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units (RSUs). 1/4 of the RSUs will vest on May 15, 2024 and the remaining RSUs will vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through each vesting date.